COMMENTARY: Addition of oral anticoagulation to antiplatelet therapy did not reduce CVD events in peripheral arterial disease

Silver, Jonathan; Tsapatsaris, Nicholas
November 2007
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p60
Academic Journal
The author reflects upon the findings of a study, investigating whether the combined use of oral anticoagulants and antiplatelet therapy in cardiovascular disease (CVD) events, in patients with peripheral arterial disease, is better than the antiplatelet therapy used alone. He states that the combination therapy increases high bleeding risk. He opines that the combined therapy should be used for patients who have developed atherothrombotic events.


Related Articles

  • Enoxaparin sodium.  // Reactions Weekly;6/17/2006, Issue 1106, p11 

    Presents the case of an elderly man who developed heparin-induced thrombocytopenia and thrombosis while receiving enoxaparin sodium for thrombosis prophylaxis. Medical history of the patient; Daily dosage of enoxaparin received by the patient; Results of the laboratory tests conducted on the...

  • Men at higher risk of recurrent thromboembolism.  // Geriatrics;Sep2006, Vol. 61 Issue 9, p8 

    The article discusses research being done on the risk of recurrent venous thromboembolism in men and women following anticoagulant therapy. It references a study published in the 2006 issue of "Lancet." The methodology of the study is described. The link between age and the risk of recurrent...

  • BOX 11-7 DISSOLVING CLOTS. Scanlon, Valerie C.; Sanders, Tina // Essentials of Anatomy & Physiology;Jan2007, p268 

    Information on dissolving clots from Chapter 11 of the book "Essentials of Anatomy & Physiology" is presented. It identifies arteries, vessels and veins that might be affected by abnormal blood clots. It offers information on streptokinase, a bacterial toxin used to dissolve blood clots, and its...

  • Heparin.  // Reactions Weekly;7/14/2007, Issue 1160, p19 

    The article describes the case of a 52-year-old man who developed heparin-induced thrombocytopenia while undergoing anticoagulation therapy with heparin. The patient received urokinase followed by a continuous infusion of heparin 10,000 U/day for 7 days and was admitted with a cerebral...

  • WARFARIN VS ASPIRIN; THE PATIENT COMPLIANCE WITH THE USE OF BLOOD THINNERS. Ahmad, Farooq; Farooq, Fahad; Farooq, Faizan; Farooq, Faiq // Professional Medical Journal;2014, Vol. 21 Issue 2, p240 

    Objectives: to determine the patient compliance with the use of blood thinners. Design: Randomized controlled trial comparing the use of warfarin and aspirin. Setting: Farooq teaching hospital Lahore, Fatima Memorial Teaching Hospital, Lahore and Allied teaching hospital Faisalabad. Period:...

  • Excessive blood clotting (Hypercoagulation).  // American Family Physician;10/15/1997, Vol. 56 Issue 6, p1601 

    Provides information about blood clotting (hypercoagulation). Effects of clot that blocks a blood vessel in the brain and in the heart; Causes of hypercoagulation; How to determine if a persons have a problem with hypercoagulation; Its treatment; Two most common blood thinners and its side effects.

  • Ximelagatran. Sander, Stephen; White, C. Michael // Formulary;Aug2004, Vol. 39 Issue 8, p398 

    Although warfarin is an effective drug in the treatment and prevention of thromboembolism,dosing complexities and drug interaction have led to its underutilization and a desire for an alternative agent. Ximelagatran (Exanta, AstraZeneca) is a novel oral anticoagulant that can be taken in...

  • Point-of-care assessment of antiplatelet agents in the perioperative period: a review. GIBBS, N. M. // Anaesthesia & Intensive Care;May2009, Vol. 37 Issue 3, p354 

    The article discusses the strengths and limitations of point-of-care techniques for the detection of antiplatelet drug effects. Global assessments of haemostasis are not specific for platelet function and are insensitive to cyclooxygenase. The most widely used technique was the laboratory...

  • HEPARINS (LOW MOLECULAR WEIGHT)/HEPARINOIDS.  // Davis's Drug Guide for Nurses, 10th edition;2007, p589 

    The article presents a nursing guide for several heparinoids, drugs used for prevention of deep vein thrombosis and pulmonary embolism after abdominal surgery, knee/hip surgery or replacement. The mechanism of action of the anticoagulants are discussed. Information on their pharmacokinetics is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics